What is gynecomastia?

The enlargement of the glandular tissue of the male breast is called gynecomastia. This condition often occurs as a result of a hormonal imbalance in the body, especially when the male body has more estrogen (female hormone) than androgen (male hormone).

Gynecomastia is commonly associated with other medical problems such as chronic kidney failure, cirrhosis of the liver, and hyperthyroidism. One prominent cause of gynecomastia may be the abuse of drugs and several medications.

The anti-psychotic drug Risperdal, manufactured by Johnson & Johnson, has spawned many lawsuits in which gynecomastia was cited as a side effect. Research has also linked this drug to the condition, and the manufacturer has listed gynecomastia as a side effect on the prescription packaging.

If you have been affected by serious side effects of a drug you should have been able to trust, the legal team at Williams Kherkher is prepared to represent you as you seek justice and compensation. Call us today at (888) 220-0640 to learn about the services we offer.

Johnson & Johnson to pay $1.75M in Risperdal trial

NorthJersey.com recently reported that a jury ordered well-known pharmaceutical manufacturer Johnson & Johnson to pay approximately $1.75 million to 21-year-old Nicholas Murray from Maryland after he developed female breasts after taking the company’s anti-psychotic drug, Risperdal.

The report said that the jury concluded that Johnson & Johnson failed to advise patients and doctors that Risperdal could trigger abnormal breast development in males. The verdict granted damages for disfigurement and mental anguish to Murray.

The recent ruling is just one out of approximately 5,400 Risperdal cases against Johnson & Johnson and its Janssen unit. According to the report, in the same state court where Murray’s case was decided, there are about 1,500 other Risperdal lawsuits that have been filed by men who developed breasts after using the anti-psychotic drug.

If you or a loved one has suffered adverse and unadvertised side effects after taking Risperdal, help is available. Contact the experienced Risperdal lawsuit attorneys of Williams Kherkher by calling us today at (888) 220-0640.

Johnson & Johnson to pay $5.6M for Risperdal death

Johnson & Johnson’s Janssen Pharmaceuticals unit was hit with a $5.6 million verdict by a California jury on October 16 over the death of Leo Liu during the company’s clinical study of Risperdal, a well-known anti-psychotic medication. The victim’s mother, Marion Liu, said that her son participated in Janssen’s human drug trial and that he died when Janssen’s employees did nothing to treat his heart condition during the drug trial.

Due to the jury’s finding that Janssen Research and Development LLC was 70% responsible for Liu’s death in the trial, the Johnson & Johnson subsidiary has been ordered to pay the $5.6 million to Liu’s family. Liu’s psychiatrist, Madeleine Valencerina, was also implemented in the trial. Valencierina allegedly received a payout from Janssen for convincing Liu to join the drug trial; she is being held liable for the remaining 30% of the settlement, bringing the total up to $8 million.

Risperdal is known to cause new or exacerbated conditions in patients who take it for anti-psychosis, and our team of lawyers at Williams Kherkher want you to know that you may be able to recover compensation for your suffering as a result of this drug. Call us today at (888) 220-0640 to learn more.

Risperdal profits trump the $2 billion in criminal penalties

Johnson & Johnson’s aggressive marketing of the antipsychotic medication Risperdal has caused quite a controversy, especially since they allegedly withheld data about potential side effects such as breast development and stroke.

Upon its initial release in 1994, Johnson & Johnson had a small market for Risperdal, as the Food and Drug Administration said it was not necessarily better than any previous version of antipsychotics, and was targeted specifically for those suffering from schizophrenia . J&J later overhauled Risperdal and branded it as a medicine for a wide range of medical problems. Johnson & Johnson formed ElderCare and prescribed Risperdal even when it was not approved for consumption by the elderly. FDA protested and has reported numerous deaths among the ones who took the drugs.

Johnson & Johnson has profited handsomely from these crimes. Although they were hit with $2 billion in penalties and settlements, J&J has seen $30 billion in Risperdal sales around the world. If you know someone who has been harmed by the side effects brought by Risperdal, you may want to seek legal assistance in order to recover financial compensation. Speak with our experienced legal team at Williams Kherkher by calling us today at (888) 220-0640.

Research shows pancreatitis increases diabetes risk

The correlation between pancreatitis and diabetes mellitus has once again been confirmed by new research, but with a twist – scientists have found that the risk of developing diabetes is much more severe for those with pancreatitis, and visa-versa.

The study involved 127 patients who have suffered and survived from a pancreatitis attack. Of the 127 participants, 28 of them developed diabetes either during index admission or during the course of the follow up. Researchers further found that patients with more severe pancreatitis attacks were at higher risk of developing diabetes.

Risperdal is known to over-activate the parathyroid gland, which in turn may increase calcium and phosphorus levels in the bloodstream. Too much calcium in the bloodstream may cause the lining of your pancreas to become inflamed, causing pancreatitis. Our legal team at Williams Kherkher is willing shed light on your inquiries about obtain financial compensation through a lawsuit if you have been harmed by this drug in any way. Call us at (888) 220-0640 today.

Am I taking drugs off label?

Until 2006, the U.S. Food and Drug Administration (FDA) did not allow Janssen Pharmaceutical to market its atypical anti-psychotic drug Risperdal for use in children due to lack of evidence that the drug is safe for pediatric use. However, a 1994 product outline revealed that the company planned to promote the drug for off-label use in children, causing the company to be involved in many lawsuits.

The use of a drug for conditions other than what it is approved for can be risky. Because doctors have no duty to disclose to their patients whether they are receiving an off label prescription or not, you should ask your doctor right away if you are receiving drugs off label. If so, ask them about how sure they are about prescribing you the drug, and how certain they are that you will benefit from it.

Some drug companies engage in unfair practices, such as selling their products for unapproved uses at consumers’ expense. If you think Risperdal has harmed you or your loved one, speak with an attorney at Williams Kherkher by calling (888) 220-0640 to learn more about taking legal action against the pharmaceutical company involved.

Smoking increases schizophrenia risk

A study published in The Lancet Psychiatry reveals a possible link between cigarette smoking and the development of schizophrenia, Forbes reported on July 13.

Researchers from Kings College London learned that daily smokers were two times more likely to develop schizophrenia. They also found that smokers were more likely to have psychosis onset about a year earlier than those who don’t smoke.

The study did not illustrate the causality of smoking as a risk factor of schizophrenia. But because psychotic illnesses have been associated with increased dopamine in the brain, researchers believe that nicotine’s effect to the brain’s dopamine level could trigger the disease.

Individuals are oftentimes prescribed with Risperdal to manage symptoms of schizophrenia. However, this drug has also been associated with adverse health effects, such as gynecomastia and diabetes. If you think taking this drug has caused you or your loved one harm, you might be eligible to take legal action against the manufacturer involved. Speak with us at Williams Kherkher by calling (888) 220-0640 today.

Hoppy beer linked to gynecomastia

A new report revealed that drinking hoppy beer may increase the risk of gynecomastia, or the enlargement of male breast tissues, KRMG stated on June 22.

Hops, which are the female flowers of the hop plant, contain phytoestrogens. These hormones are estrogen-like compounds naturally found in plants. Some experts believe phytoestrogens mimic the effects of true estrogen, contributing to the risk of gynecomastia.

Although hops have only been tentatively linked to male breast enlargement, there are prescription drugs that have been more closely tied with this condition. For instance, Risperdal, an atypical anti-psychotic drug, has been established as a cause of gynecomastia. If you or your loved one has suffered from breast enlargement after taking this drug, a lawyer at Williams Kherkher is willing to see if your situation qualifies you to file a claim. Call us at (888) 220-0640 to learn more about taking legal action against the drug manufacturer involved.

Persistent pancreatitis could indicate pancreatic cancer

Pancreatitis, or the inflammation of the pancreas, is a condition that can result from many different causes, such as gallstone formation, alcoholism, heredity, and use of certain medications. With prompt diagnosis, proper treatment, and a switch to a healthier diet, pancreatitis may manifest as a one-time episode and may not recur at all.

In some cases, however, pancreatitis could be persistent and chronic. Chronic inflammation of the pancreas could be indicative of pancreatic cancer. If you are suffering from recurrent pancreatitis, ask your doctor about your risk of pancreatic cancer. Your risk is especially high if any of the following apply to you:

  • Obese/overweight
  • African-American
  • Family history of pancreatic cancer
  • Diabetes

Unfortunately, the anti-psychotic drug Risperdal may increase your risk of recurrent pancreatitis. This in turn could trigger cancer formation in the tissues of your pancreas. If Risperdal has caused you or your loved one to develop pancreatic cancer, a lawyer at Williams Kherkher might be able to represent you in a case against the pharmaceutical company involved. Call us at (888) 220-0640 to learn more about taking legal action today.

J&J will pay Arkansas $7.8 million to settle Risperdal’s diabetes risk

Johnson & Johnson (J&J) has entered a settlement agreement worth $7.8 million over the state of Arkansas’ allegations that the company misled patients and doctors about the diabetes risk of its anti-psychotic drug Risperdal, Bloomberg Business reported on May 22.

The settlement, which ended close to eight decades of legal brawl over Risperdal’s diabetes risk, came amid various state lawsuits filed against the company. Risperdal is blamed for a myriad of different adverse effects, including gynecomastia, or the enlargement of breast tissue in males. But despite issues of side-effects, an emailed statement by a company spokesperson said the company’s recent settlement with Arkansas doesn’t mean admittance of liability.

Facing large pharmaceutical companies in a fight for justice and compensation requires not just legal expertise and resources, but also tenacity and will power. At Williams Kherkher, we handle each of our cases with diligent assertiveness and compassion. Call us at (888) 220-0640 to learn more about how we might be able to help you file a case if ever you’ve been hurt by a defective drug.

1 2 3 4 5
SEO for Lawyers